These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6333485)
21. Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2',3' cyclic nucleotide 3' phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE. Birnbaum G; Kotilinek L; Schlievert P; Clark HB; Trotter J; Horvath E; Gao E; Cox M; Braun PE J Neurosci Res; 1996 May; 44(4):381-96. PubMed ID: 8739158 [TBL] [Abstract][Full Text] [Related]
22. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis. Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057 [TBL] [Abstract][Full Text] [Related]
23. Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat. Williams RM; Moore MJ J Exp Med; 1973 Oct; 138(4):775-83. PubMed ID: 4126546 [TBL] [Abstract][Full Text] [Related]
24. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Gold DP; Schroder K; Powell HC; Kelly CJ Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811 [TBL] [Abstract][Full Text] [Related]
25. Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis. Li J; Chen W; Li Y; Chen Y; Ding Z; Yang D; Zhang X Int J Clin Exp Pathol; 2015; 8(9):11149-56. PubMed ID: 26617835 [TBL] [Abstract][Full Text] [Related]
26. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Mohamed A; Shoker A; Bendjelloul F; Mare A; Alzrigh M; Benghuzzi H; Desin T Biomed Sci Instrum; 2003; 39():440-5. PubMed ID: 12724933 [TBL] [Abstract][Full Text] [Related]
27. Prolonged suppression of experimental allergic encephalomyelitis in the Lewis rats: the effect of lipopolysaccharides. Raziuddin S; Morrison DC J Immunol; 1982 Mar; 128(3):1486-9. PubMed ID: 6173441 [TBL] [Abstract][Full Text] [Related]
28. Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitis. Constantinescu CS; Ventura E; Hilliard B; Rostami A Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):471-91. PubMed ID: 8576541 [TBL] [Abstract][Full Text] [Related]
30. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats. Chelmicka-Schorr E; Wiegmann K; Wollmann R; Arnason BG; Kim DH J Autoimmun; 1998 Aug; 11(4):329-34. PubMed ID: 9776710 [TBL] [Abstract][Full Text] [Related]
31. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats. Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002 [TBL] [Abstract][Full Text] [Related]
32. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis. Matsumoto Y; Kawai K; Tomita Y; Fujiwara M Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693 [TBL] [Abstract][Full Text] [Related]
33. Analysis of the cellular infiltrate in the iris during experimental autoimmune encephalomyelitis. de Vos AF; Dick AD; Klooster J; Broersma L; McMenamin PG; Kijlstra A Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3001-10. PubMed ID: 10967057 [TBL] [Abstract][Full Text] [Related]
34. Role of retinal pigment epithelium in the development of experimental autoimmune uveitis. Konda BR; Pararajasegaram G; Wu GS; Stanforth D; Rao NA Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):40-7. PubMed ID: 8300362 [TBL] [Abstract][Full Text] [Related]
35. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis. Killen JA; Swanborg RH J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781 [TBL] [Abstract][Full Text] [Related]
36. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat. Stohl W; Gonatas NK J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523 [TBL] [Abstract][Full Text] [Related]
37. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560 [TBL] [Abstract][Full Text] [Related]
38. Autoimmune effector cells. VIII. Cellular requirements for the induction of autoreactive T cells of experimental allergic encephalomyelitis in nonimmune rats. Silberg DG; Swanborg RH J Immunol; 1986 Apr; 136(7):2432-6. PubMed ID: 3485150 [TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system. Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034 [TBL] [Abstract][Full Text] [Related]